Independent Drug Value Assessment Act
Sponsored By: Representative Speier, Jackie [D-CA-14]
Unknown
Summary
Independent Drug Value Assessment Act This bill requires the Office of the Assistant Secretary for Planning and Evaluation to contract with outside entities to conduct independent value assessments of approved drugs (i.e., economic analysis of the benefits to patients and the health care system).
Personalized for You
How does this bill affect your finances?
Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Bill Overview
No Economic Impacts Identified for this Bill
Sponsors & CoSponsors
Sponsor
Speier, Jackie [D-CA-14]
CA • D
Cosponsors
Rep. Nadler, Jerrold [D-NY-12]
NY • D
Sponsored 11/16/2022
Rep. Porter, Katie [D-CA-47]
CA • D
Sponsored 11/16/2022
Roll Call Votes
No roll call votes available for this bill.
View on Congress.gov